Armistice Capital, LLC, Director, 10% Owner at TENAX THERAPEUTICS, INC. (TENX), bought 86,000 shares at $1.39 ($123K) on 2020-09-03, disclosed to the SEC on 2020-09-03.
Open-market purchase of $123k TENX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.46 | 30,000 | $44K | 35.5% |
| 2 | $1.47 | 20,000 | $29K | 23.9% |
| 3 | $1.39 | 36,000 | $50K | 40.6% |
| Total | $1.43 avg | 86,000 | $123K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |